4

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: March 14, 2013
Period of Report: March 12, 2013
Accession Number: 0001144204-13-015174

View Document ↗ View on SEC.gov ↗